Drug Database
Back to search

Canada· CA-DIN-02254336

ACID CONCENTRATE A1222

A hemodialytics, concentrates product containing magnesium chloride + dextrose + sodium chloride + acetic acid, registered in Canada by CHIEF MEDICAL SUPPLIES LTD. The same ATC class is registered in 2 of our 19 countries.

ATC B05ZA

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedACID CONCENTRATE A1222ATCB05ZAREGISTER NO.CA-DIN-02254336PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about magnesium chloride + dextrose + sodium chloride + acetic acidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Magnesium chloride + dextrose + sodium chloride + acetic acid is registered in 2 of 19 countries.

Countries holding a registration under ATC B05ZA (hemodialytics, concentrates), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 1 of them publish a price we can compare per daily dose
Search magnesium chloride + dextrose + sodium chloride + acetic acid products by name

Magnesium chloride + dextrose + sodium chloride + acetic acid · ATC B05ZA

2 / 19 countries

  • Canada
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
MAGNESIUM CHLORIDE + DEXTROSE + SODIUM CHLORIDE + ACETIC ACID
Manufacturer
CHIEF MEDICAL SUPPLIES LTD
Country
Canada (CA)
ATC code
B05ZA
ATC class
Hemodialytics, concentrates
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under B05ZA

Hemodialytics, concentrates, as other registers publish it.

All magnesium chloride + dextrose + sodium chloride + acetic acid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/980236a9-06b7-4c2e-9174-5d7206be448f
GET /v1/drugs/980236a9-06b7-4c2e-9174-5d7206be448f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02254336",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "HAEMODIALYSIS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B05ZA",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "73923",
  "strengths": [
    "6.86 G",
    "49.5 G",
    "263 G",
    "10.81 G",
    "9.92 G",
    "6.71 G"
  ],
  "ahfs_class": null,
  "substances": [
    "MAGNESIUM CHLORIDE",
    "DEXTROSE",
    "SODIUM CHLORIDE",
    "ACETIC ACID",
    "CALCIUM CHLORIDE",
    "POTASSIUM CHLORIDE"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about magnesium chloride + dextrose + sodium chloride + acetic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console